ArticleJournal for immunotherapy of cancer2017

Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy.

Ryan Urak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.